Detalhe da pesquisa
1.
Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
Proc Natl Acad Sci U S A
; 110(10): E928-37, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23431165
2.
PET-CT imaging in patients with chronic sternal wound infections prior to reconstructive surgery: A case series.
J Plast Reconstr Aesthet Surg
; 68(8): 1132-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25986418
3.
Erratum to: Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism.
Fibrogenesis Tissue Repair
; 8: 4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774218
4.
Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions.
J Invest Dermatol
; 133(12): 2664-2671, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652794
5.
Thrombospondin 1 is a key mediator of transforming growth factor ß-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism.
Fibrogenesis Tissue Repair
; 4(1): 9, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21453480